Literature DB >> 10959488

The expression of Cdk5, p35, p39, and Cdk5 kinase activity in developing, adult, and aged rat brains.

D C Wu1, Y P Yu, N T Lee, A C Yu, J H Wang, Y F Han.   

Abstract

The expression of cyclin-dependent kinase 5 (Cdk5) and its regulatory subunits, p35 and p39, was investigated in rat brain from embryonic day 12 (E12) to postnatal 18 months (18M). The Cdk5 protein levels increased from E12 to postnatal day 7 (P7) and remained at this level until 18M. The Cdk5 kinase activity and the levels of both p35 mRNA and protein were low at E12, became prominent at E18-P14 but then decreased in the adult and aged rat brains of 3M to 18M. In comparison, the expression pattern of p39 appeared to have an inverse relationship to that of Cdk5 and p35. In regional distribution studies, p35 protein levels and Cdk5 kinase activity were significantly higher in the cerebral cortex and hippocampus, but lower in the cerebellum and striatum. These results suggested that Cdk5, p35 and p39 might have region-specific and developmental stage-specific functions in rat brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10959488     DOI: 10.1023/a:1007544106645

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

1.  Purification and characterization of a novel proline-directed protein kinase from bovine brain.

Authors:  J Lew; K Beaudette; C M Litwin; J H Wang
Journal:  J Biol Chem       Date:  1992-07-05       Impact factor: 5.157

2.  Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.

Authors:  M Zheng; C L Leung; R K Liem
Journal:  J Neurobiol       Date:  1998-05

3.  An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator.

Authors:  D Tang; J Yeung; K Y Lee; M Matsushita; H Matsui; K Tomizawa; O Hatase; J H Wang
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain.

Authors:  K Ishiguro; S Kobayashi; A Omori; M Takamatsu; S Yonekura; K Anzai; K Imahori; T Uchida
Journal:  FEBS Lett       Date:  1994-04-04       Impact factor: 4.124

Review 6.  The cyclin-dependent protein kinases and the control of cell division.

Authors:  M Dorée; S Galas
Journal:  FASEB J       Date:  1994-11       Impact factor: 5.191

Review 7.  Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.

Authors:  K Imahori; T Uchida
Journal:  J Biochem       Date:  1997-02       Impact factor: 3.387

8.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.

Authors:  G N Patrick; L Zukerberg; M Nikolic; S de la Monte; P Dikkes; L H Tsai
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

9.  Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A.

Authors:  K T Shetty; W T Link; H Jaffe; J Wang; H C Pant
Journal:  J Neurochem       Date:  1995-06       Impact factor: 5.372

10.  Modulation of GSK-3-catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases.

Authors:  T J Singh; T Zaidi; I Grundke-Iqbal; K Iqbal
Journal:  FEBS Lett       Date:  1995-01-16       Impact factor: 4.124

View more
  23 in total

1.  p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.

Authors:  J Ko; S Humbert; R T Bronson; S Takahashi; A B Kulkarni; E Li; L H Tsai
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

2.  Hypomyelination phenotype caused by impaired differentiation of oligodendrocytes in Emx1-cre mediated Cdk5 conditional knockout mice.

Authors:  Xiaojuan He; Satoru Takahashi; Hiromi Suzuki; Tsutomu Hashikawa; Ashok B Kulkarni; Katsuhiko Mikoshiba; Toshio Ohshima
Journal:  Neurochem Res       Date:  2011-01-06       Impact factor: 3.996

3.  Decreased expression of p39 is associated with a poor prognosis in human hepatocellular carcinoma.

Authors:  Jeng-Wei Lu; Jan-Gowth Chang; Kun-Tu Yeh; Rong-Ming Chen; Jeffrey J P Tsai; Rouh-Mei Hu
Journal:  Med Oncol       Date:  2010-10-09       Impact factor: 3.064

4.  Oligodendrocyte-specific loss of Cdk5 disrupts the architecture of nodes of Ranvier as well as learning and memory.

Authors:  Fucheng Luo; Jessie Zhang; Kathryn Burke; Rita R Romito-DiGiacomo; Robert H Miller; Yan Yang
Journal:  Exp Neurol       Date:  2018-05-02       Impact factor: 5.330

5.  Loss of Cdk5 function in the nucleus accumbens decreases wheel running and may mediate age-related declines in voluntary physical activity.

Authors:  Gregory N Ruegsegger; Ryan G Toedebusch; Thomas E Childs; Kolter B Grigsby; Frank W Booth
Journal:  J Physiol       Date:  2016-09-15       Impact factor: 5.182

Review 6.  Contribution of hypoxia to Alzheimer's disease: is HIF-1alpha a mediator of neurodegeneration?

Authors:  O O Ogunshola; X Antoniou
Journal:  Cell Mol Life Sci       Date:  2009-09-11       Impact factor: 9.261

7.  Sp1 and Sp3 regulate transcription of the cyclin-dependent kinase 5 regulatory subunit 2 (p39) promoter in neuronal cells.

Authors:  Alvaro Valin; Julie D Cook; Sarah Ross; Christi L Saklad; Grace Gill
Journal:  Biochim Biophys Acta       Date:  2009-03

8.  Cdk5 is essential for adult hippocampal neurogenesis.

Authors:  Diane C Lagace; David R Benavides; Janice W Kansy; Marina Mapelli; Paul Greengard; James A Bibb; Amelia J Eisch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

9.  p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.

Authors:  Andrew N Bankston; Wenqi Li; Hui Zhang; Li Ku; Guanglu Liu; Filomena Papa; Lixia Zhao; James A Bibb; Franca Cambi; Seema K Tiwari-Woodruff; Yue Feng
Journal:  J Biol Chem       Date:  2013-05-03       Impact factor: 5.157

10.  p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.

Authors:  Kathleen I Seyb; Sabah Ansar; Guibin Li; Jennifer Bean; Mary L Michaelis; Rick T Dobrowsky
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.